Biologics: Targets and Therapy
Volume 11, 2017 - Issue
Open access
136
Views
7
CrossRef citations to date
0
Altmetric
Review
Octreotide long-acting repeatable in the treatment of neuroendocrine tumors: patient selection and perspectives
Hanford Yau1 Division of Endocrinology, Diabetes, and Metabolism, University of California, San Francisco (Fresno Division), Fresno, CA, USACorrespondence[email protected]
, Mustafa Kinaan2 Division of Internal Medicine, University of Central Florida College of Medicine, Orlando, FL, USA
, Suzanne L Quinn3 Division of Endocrinology, Diabetes, and Metabolism, Orlando VA Medical Center, Orlando, FL, USA
& Andreas G Moraitis3 Division of Endocrinology, Diabetes, and Metabolism, Orlando VA Medical Center, Orlando, FL, USA
Pages 115-122
|
Published online: 06 Dec 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.